COVID-19与流感住院患者急性肾损伤发生率、恢复及长期肾脏结局比较
这项回顾性队列研究比较了COVID-19住院患者与流感住院患者的急性肾损伤(AKI)发生率及结局。共纳入2425例患者,COVID-19患者AKI发生率23%,流感患者13%;COVID-19患者发生AKI风险更高(aHR=1.58),AKI后院内死亡风险更高(aHR=3.55),AKI恢复率更低(aHR=0.47),但长期随访中新发CKD和eGFR下降≥25%无显著差异。
要点
- COVID-19住院患者AKI发生率为23%,高于流感患者的13%。
- COVID-19患者发生AKI的风险显著高于流感患者(aHR=1.58)。
- 合并AKI时,COVID-19患者院内死亡风险显著高于流感患者。
核心结论
- COVID-19患者AKI发生率和死亡率显著高于流感患者,但长期幸存者的肾脏恢复情况相似。
主要发现
- COVID-19和流感患者总体AKI发生率分别为23%和13%。
- 与流感相比,COVID-19患者发生AKI的风险增加(aHR=1.58;95%CI 1.29-1.94)。
- 合并AKI时,COVID-19患者院内死亡风险高于流感患者(aHR=3.55;95%CI 2.11-5.97)。
- 存活出院患者中,COVID-19患者AKI恢复率更低(aHR=0.47;95%CI 0.36-0.62)。
- 随访≥90天的患者中,新发CKD(aHR=1.24;95%CI 0.86-1.78)和eGFR下降≥25%(aHR=1.36;95%CI 0.97-1.90)在两组间无显著差异。
临床怎么用
- 临床应关注COVID-19住院患者的AKI风险,尤其合并AKI时死亡风险更高。
- 对COVID-19合并AKI的出院患者,需监测肾功能恢复及长期肾脏结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Acute kidney injury (AKI) is a common complication in patients with severe COVID-19. We sought to compare the AKI incidence and outcomes among patients hospitalized with COVID-19 and with influenza. METHODS: This was a retrospective cohort study of patients with COVID-19 hospitalized between March and May 2020 and historical controls hospitalized with influenza A or B between January 2017 and December 2019 within a large health care system. Cox proportional hazards models were used to compare the risk of AKI during hospitalization. Secondary outcomes included AKI recovery, mortality, new-onset chronic kidney disease (CKD), and ≥25% estimated glomerular filtration rate (eGFR) decline. RESULTS: A total of 2425 patients were included; 1091 (45%) had COVID-19, and 1334 (55%) had influenza. The overall AKI rate was 23% and 13% in patients with COVID-19 and influenza, respectively. Compared with influenza, hospitalized patients with COVID-19 had an increased risk of developing AKI (adjusted hazard ratio [aHR] = 1.58; 95% confidence interval [CI], 1.29-1.94). Patients with AKI were more likely to die in the hospital when infected with COVID-19 versus influenza (aHR = 3.55; 95% CI, 2.11-5.97). Among patients surviving to hospital discharge, the rate of AKI recovery was lower in patients with COVID-19 (aHR = 0.47; 95% CI, 0.36-0.62); however, among patients followed for ≥90 days, new-onset CKD (aHR = 1.24; 95% CI, 0.86-1.78) and ≥25% eGFR decline at the last follow-up (aHR = 1.36, 95% CI, 0.97-1.90) were not significantly different between the cohorts. CONCLUSION: AKI and mortality rates are significantly higher in patients with COVID-19 than influenza; however, kidney recovery among long-term survivors appears to be similar.
引用
- Strohbehn IA, Zhao S, Seethapathy H, et al. Acute Kidney Injury Incidence, Recovery, and Long-term Kidney Outcomes Among Hospitalized Patients With COVID-19 and Influenza. Kidney Int Rep. 2021. PMID: 34307971. doi:10.1016/j.ekir.2021.07.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。